Detalhe da pesquisa
1.
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
N Engl J Med
; 382(1): 41-50, 2020 01 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31751012
2.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(18): 1711-1723, 2020 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32955177
3.
A novel self-organizing embryonic stem cell system reveals signaling logic underlying the patterning of human ectoderm.
Development
; 146(20)2019 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-31519692
4.
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(2): 113-125, 2018 01 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29151359
5.
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer.
Future Oncol
; 17(35): 4827-4835, 2021 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34723634
6.
Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.
Jpn J Clin Oncol
; 49(1): 29-36, 2019 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30508196
7.
Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples.
Cancer Sci
; 109(4): 1177-1184, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-29363250
8.
Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial.
Cancer Sci
; 109(6): 1930-1938, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29697876
9.
Double deletion of melanocortin 4 receptors and SAPAP3 corrects compulsive behavior and obesity in mice.
Proc Natl Acad Sci U S A
; 110(26): 10759-64, 2013 Jun 25.
Artigo
Inglês
| MEDLINE | ID: mdl-23754400
10.
Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072).
Cancer
; 121(17): 2933-41, 2015 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26033286
11.
Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non-Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic.
J Mol Diagn
; 26(1): 73-84, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37981090
12.
VLK drives extracellular phosphorylation of EphB2 to govern the EphB2-NMDAR interaction and injury-induced pain.
bioRxiv
; 2024 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38562765
13.
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 379(9829): 1879-86, 2012 May 19.
Artigo
Inglês
| MEDLINE | ID: mdl-22595799
14.
The septate junction component bark beetle is required for Drosophila intestinal barrier function and homeostasis.
iScience
; 26(6): 106901, 2023 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37332603
15.
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA.
Clin Cancer Res
; 29(17): 3340-3351, 2023 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37379430
16.
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
JAMA Netw Open
; 6(8): e2327351, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37556141
17.
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 6: e2100372, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35952319
18.
Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non-small-cell Lung Cancer: LAURA Trial in Progress.
Clin Lung Cancer
; 22(4): 371-375, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33558193
19.
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).
J Clin Oncol
; 36(26): 2702-2709, 2018 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30059262
20.
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; : JCO2018783118, 2018 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-30153097